Cidara Therapeutics's total assets for Q3 2024 were $162.33M, a decrease of -6.36% from the previous quarter. CDTX total liabilities were $46.70M for the fiscal quarter, a 10.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.